GJA3

Cataracts, Congenital Zonular Pulverulent 3

Clinical Characteristics
Ocular Features: 

Bilateral dust-like lens opacities are diagnosed at a median age of 5 years but have been seen at 6 months of age.  These affect the embryonal, fetal, and infantile nucleus and are often surrounded by snowflake- or needle-like opacities throughout the lens cortex.  The dust-like particles may be multicolored and impart a haze to the lens.  Evidence for progression is suggested by the fact that about half of such affected patients require cataract surgery as adults.  No other ocular abnormalities are present.

There is considerable phenotypic heterogeneity.

Systemic Features: 

No systemic abnormalities are associated.

Genetics

Heterozygous mutations in GJA3 (13q11) seem to be responsible for the opacities.  For another somewhat similar form of autosomal dominant congenital cataract see Cataracts, Congenital Zonular Pulverulent 1 (116200).

Pedigree: 
Autosomal dominant
Treatment
Treatment Options: 

Visually significant cataracts may be removed.

References
Article Title: 

Cataracts, Coppock-Like

Clinical Characteristics
Ocular Features: 

Coppock-like cataracts consist of bilateral progressive opacities of the embryonic lens nucleus.  They are characterized by a pulverulent opacification with a gray disc appearance associated with variable zonular opacities.  Visual symptoms often begin during adolescence and some patients require cataract surgery by the 5th decade of life. 

Systemic Features: 

There is no systemic disease associated with this type of cataract.  

Genetics

CCL cataracts are embryonic in origin, developing during the time when gamma-crystallin genes are active.  The gamma E-crystallin gene is a pseudogene and the mutation in its promoter reactivates its activity 10-fold.  It is postulated that overexpression of the gamma-crystallin fragment is responsible for the nuclear opacification.

Mutations in at least 3 genes have been associated with this type of cataract.  In some families the mutations are in the CRYGC gene (2q33-q35), and in others mutations in CRYBB2 (22q11.2-q12.2) seem to be responsible.  It is of interest that one form of congenital cerulean cataract, CCA3 (608983), found in a single family, results in mutations in CRYGD also located at 22q11.2-q12.2.  A five-generation Chinese family has been reported in which mutations in GJA3 (13q12.11) was associated with this type of lens opacity.

Other forms of autosomal dominantly inherited, congenital, progressive lens opacities include congenital cerulean (115660, 601547, 608983, 610202), Volkmann type (115665), lamellar (116800), and congenital posterior polar (116600) cataracts. Due to clinical heterogeneity, it is not always possible to classify specific families based on the appearance and natural history of the lens opacities alone.

Pedigree: 
Autosomal dominant
Treatment
Treatment Options: 

Cataract surgery may be indicated.

References
Article Title: 

Cataracts, Congenital, Autosomal Dominant

Clinical Characteristics
Ocular Features: 

Most cataracts arise as part of the aging process.  However, early onset lens opacities may be familial, often transmitted in an autosomal dominant pattern.  These have a highly variable appearance and may be unilateral or bilateral.  There can be considerable interocular asymmetry in morphology, density, location, and rate of progression.  This is also true of intrafamilial characteristics.  Age of onset is variable. 

Systemic Features: 

There are no associated systemic abnormalities. 

Genetics

At least 25 loci scattered among multiple chromosome have been identified to cause simple autosomal dominant cataracts (See 604219).  It is not yet possible to make phenotypic - genotypic correlations due to the large variation in clinical characteristics. 

 

Pedigree: 
Autosomal dominant
Treatment
Treatment Options: 

Lens extraction is indicated when the opacities become visually significant. 

References
Article Title: 
Subscribe to RSS - GJA3